Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Crinetics Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues9.25.1
            Revenue growth81.0% 
Cost of goods sold11.26.6
Gross profit-1.9-1.5
            Gross margin-21.0%-30.1%
General and administrative1.91.5
EBIT-9.1-6.0
            EBIT margin-98.9%-118.5%
Pre-tax income-9.2-6.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-9.2-6.0
            Net margin-99.2%-118.0%
 
Diluted EPS($6.68)($5.96)
Shares outstanding (diluted)1.41.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy